Key facts
- Inject once a week under the skin of your stomach area, upper leg or upper arm, on the same day each week if you can.
- Do not change your dose unless your doctor tells you to. The starting dose is 2.5 mg weekly for four weeks, then your doctor will increase it.
- Stop using it and get urgent medical help if you have severe, persistent stomach pain, which could be acute pancreatitis, or signs of a severe allergic reaction.
- Low blood sugar can occur if you use it with a sulphonylurea or insulin, so test your blood glucose as instructed.
- It should not be used in pregnancy and should not be given to anyone under 18 years of age.
Who should not take tirzepatide
The leaflet says not to take it if any of these apply to you.
- If you are allergic to tirzepatide or any of the other ingredients of this medicine
Check with a doctor or pharmacist first
Tell them before you take it if any of these apply to you.
- Severe problems with food digestion or food staying in your stomach longer than normal (including severe gastroparesis)
- You have ever had pancreatitis (inflammation of the pancreas)
- Eye problems (diabetic retinopathy or macular oedema)
- You use a sulphonylurea or insulin for your diabetes, as low blood sugar (hypoglycaemia) can occur and your doctor may need to change your dose
- Loss of fluids/dehydration (for example from vomiting, nausea or diarrhoea) when starting treatment, which may lead to a decrease in kidney function. Drink plenty of fluids
- You are due to have surgery under anaesthesia
Show 2 moreShow fewer
- You have a liver or kidney disease (the medicine contains benzyl alcohol, which can build up in the body)
- Not for children and adolescents under 18 years of age
How to take tirzepatide
- Inject once a week under the skin (subcutaneously) of your stomach area, upper leg or upper arm, choosing a different injection site each time. You may need help to inject in your upper arm.
- The starting dose is 2.5 mg once a week for four weeks, then 5 mg once a week. Your doctor may increase it in 2.5 mg steps up to 15 mg, staying on each dose for at least 4 weeks. Do not change your dose unless your doctor tells you to.
- Use it at any time of day, with or without meals, on the same day each week if you can. You can change the injection day if it has been at least 3 days since your last injection.
- If you miss a dose by 4 days or less, inject it as soon as you remember. If more than 4 days, skip it and inject on your usual day. Never use a double dose.
- Read the Instructions for Use before using the pen. Each pen contains 4 doses and should be discarded after the 4th dose or 30 days after first use.
Side effects
Get medical help straight away
The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.
- Inflamed pancreas (acute pancreatitis) causing severe pain in the stomach and back that does not go away (uncommon)
- Severe, persistent pain in the stomach area (abdomen), with or without nausea and vomiting, which could be a sign of acute pancreatitis: stop using the medicine and seek urgent medical help (uncommon)
- Severe allergic reactions (e.g. anaphylactic reaction, angioedema), with symptoms such as breathing problems, rapid swelling of the lips, tongue and/or throat with difficulty swallowing, and a fast heartbeat (rare)
How common each side effect is
Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.
Very common
More than 1 in 10 people
- Low blood sugar (hypoglycaemia) when tirzepatide is used for type 2 diabetes with medicines that contain a sulphonylurea and/or insulin
- Feeling sick (nausea)
- Diarrhoea
- Being sick (vomiting)
- Stomach (abdominal) pain
- Constipation
Common
Up to 1 in 10 people
- Low blood sugar (hypoglycaemia) when tirzepatide is used for type 2 diabetes with both metformin and a sodium-glucose co-transporter 2 inhibitor
- Allergic reaction (hypersensitivity) (e.g. rash, itching, and eczema)
- Dizziness observed in patients treated for weight management
- Low blood pressure observed in patients treated for weight management
- Feeling less hungry (decreased appetite) observed in patients treated for type 2 diabetes
- Indigestion (dyspepsia)
- Bloating of the stomach
- Burping (eructation)
- Gas (flatulence)
- Reflux or heartburn (gastroesophageal reflux disease, GORD)
Show 10 moreShow fewer
- Hair loss observed in patients treated for weight management
- Feeling tired (fatigue)
- Injection site reactions (e.g. itching or redness)
- Fast pulse
- Increased levels of pancreatic enzymes (such as lipase and amylase) in blood
- Increased calcitonin levels in blood
- Gallstones
- Vomiting (when treated for type 2 diabetes)
- Stomach (abdominal) pain (when treated for type 2 diabetes)
- Constipation (when treated for type 2 diabetes)
Uncommon
Up to 1 in 100 people
- Inflamed pancreas (acute pancreatitis)
- Low blood sugar (hypoglycaemia) when tirzepatide is used with metformin for type 2 diabetes
- Weight loss observed in patients treated for type 2 diabetes
- Injection site pain
- Cholecystitis (infection of the gallbladder) observed in patients treated for weight management
- Changed sense of taste
- Change in skin sensation
- A delay in the emptying of the stomach
- Fast pulse (when used for weight management)
- Increased levels of amylase (in weight management)
Show 2 moreShow fewer
- Increased calcitonin levels in blood (when used for type 2 diabetes)
- Gallstones (when used for type 2 diabetes)
Rare
Up to 1 in 1,000 people
- Severe allergic reactions (e.g. anaphylactic reaction, angioedema)
If you get a side effect, you can report it to the regulator through the Yellow Card scheme.
Pregnancy and breastfeeding
Do not use during pregnancy as the effects on an unborn child are not known. Ask your doctor for advice if you are pregnant, think you may be or plan a baby, and use contraception while using it. It is unknown whether tirzepatide passes into breast milk, so talk to your doctor before using it if you are breast-feeding or plan to breast-feed.
Taking it with other medicines
The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.
- Any other medicines you are using, have recently used or might use
- Sulphonylureas (another diabetes medicine), as your doctor may need to change the dose
- Insulin, as your doctor may need to change the dose
- Oral contraceptives (if you are a woman with obesity or overweight, consider a barrier method or a non-oral contraceptive for 4 weeks after starting and after each dose increase)
Where this comes from
Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.
- Product
- Mounjaro 7.5 mg Kwikpen Solution For Injection In Pre-Filled Pen
- Product licence
- PLPI457631014
- Leaflet dated
- Checked against the leaflet
- Automated check
- 38 of 39 side effects matched to the wording of the leaflet. 1 could not be matched and need a manual check
Other makers of tirzepatide publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.
Read the official leaflet Original on the MHRA site How we make these pages